Does Demant A/S (CPH:DEMANT) Have A Good P/E Ratio?

The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll apply a basic P/E ratio analysis to Demant A/S's (CPH:DEMANT), to help you decide if the stock is worth further research. Demant has a price to earnings ratio of 37.58, based on the last twelve months. In other words, at today's prices, investors are paying DKK37.58 for every DKK1 in prior year profit.

Check out our latest analysis for Demant

Advertisement

How Do I Calculate Demant's Price To Earnings Ratio?

The formula for price to earnings is:

Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Or for Demant:

P/E of 37.58 = DKK225.60 ÷ DKK6.00 (Based on the trailing twelve months to December 2019.)

Is A High Price-to-Earnings Ratio Good?

A higher P/E ratio means that buyers have to pay a higher price for each DKK1 the company has earned over the last year. That is not a good or a bad thing per se, but a high P/E does imply buyers are optimistic about the future.

How Does Demant's P/E Ratio Compare To Its Peers?

We can get an indication of market expectations by looking at the P/E ratio. The image below shows that Demant has a lower P/E than the average (46.1) P/E for companies in the medical equipment industry.

CPSE:DEMANT Price Estimation Relative to Market, February 22nd 2020
CPSE:DEMANT Price Estimation Relative to Market, February 22nd 2020

Demant's P/E tells us that market participants think it will not fare as well as its peers in the same industry. Since the market seems unimpressed with Demant, it's quite possible it could surprise on the upside. If you consider the stock interesting, further research is recommended. For example, I often monitor director buying and selling.

How Growth Rates Impact P/E Ratios

Probably the most important factor in determining what P/E a company trades on is the earnings growth. Earnings growth means that in the future the 'E' will be higher. And in that case, the P/E ratio itself will drop rather quickly. Then, a lower P/E should attract more buyers, pushing the share price up.

Demant shrunk earnings per share by 18% over the last year. But over the longer term (5 years) earnings per share have increased by 4.7%.

Don't Forget: The P/E Does Not Account For Debt or Bank Deposits

One drawback of using a P/E ratio is that it considers market capitalization, but not the balance sheet. Thus, the metric does not reflect cash or debt held by the company. Theoretically, a business can improve its earnings (and produce a lower P/E in the future) by investing in growth. That means taking on debt (or spending its cash).

While growth expenditure doesn't always pay off, the point is that it is a good option to have; but one that the P/E ratio ignores.

How Does Demant's Debt Impact Its P/E Ratio?

Demant's net debt is 13% of its market cap. This could bring some additional risk, and reduce the number of investment options for management; worth remembering if you compare its P/E to businesses without debt.

The Verdict On Demant's P/E Ratio

Demant's P/E is 37.6 which is above average (16.8) in its market. With modest debt but no EPS growth in the last year, it's fair to say the P/E implies some optimism about future earnings, from the market.

When the market is wrong about a stock, it gives savvy investors an opportunity. If the reality for a company is better than it expects, you can make money by buying and holding for the long term. So this free visualization of the analyst consensus on future earnings could help you make the right decision about whether to buy, sell, or hold.

Of course, you might find a fantastic investment by looking at a few good candidates. So take a peek at this free list of companies with modest (or no) debt, trading on a P/E below 20.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

About CPSE:DEMANT

Demant

Operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally.

Very undervalued with reasonable growth potential.

Advertisement

Weekly Picks

TA
Talos
TSLA logo
Talos on Tesla ·

The "Physical AI" Monopoly – A New Industrial Revolution

Fair Value:US$665.3637.3% undervalued
39 users have followed this narrative
14 users have commented on this narrative
19 users have liked this narrative
MA
CSG logo
Marek_Trnka on CSG ·

Czechoslovak Group - is it really so hot?

Fair Value:€5548.6% undervalued
40 users have followed this narrative
1 users have commented on this narrative
13 users have liked this narrative
AL
alex30free
SECARE logo
alex30free on Swedencare ·

The Compound Effect: From Acquisition to Integration

Fair Value:SEK 46.2846.8% undervalued
11 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

TO
Tokyo
AIR logo
Tokyo on Airbus ·

EU#6 - From Political Experiment to Global Aerospace Power

Fair Value:€231.4116.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DO
Double_Bubbler
MDAI logo
Double_Bubbler on Spectral AI ·

Spectral AI: First of Its Kind Automated Wound Healing Prediction

Fair Value:US$569.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DO
Double_Bubbler
ENSI logo
Double_Bubbler on EnSilica ·

Why EnSilica is Worth Possibly 13x its Current Price

Fair Value:UK£590.1% undervalued
114 users have followed this narrative
17 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

DA
davidlsander
UBI logo
davidlsander on Ubisoft Entertainment ·

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.886.3% undervalued
59 users have followed this narrative
5 users have commented on this narrative
25 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0227.7% undervalued
1072 users have followed this narrative
6 users have commented on this narrative
32 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$603.2233.5% undervalued
1274 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative

Trending Discussion

Advertisement